These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 30392731)

  • 1. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol and Drug Use Collaborators
    Lancet Psychiatry; 2018 Dec; 5(12):987-1012. PubMed ID: 30392731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Risk Factors Collaborators
    Lancet; 2020 Oct; 396(10258):1223-1249. PubMed ID: 33069327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.
    Degenhardt L; Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Hall WD; Freedman G; Burstein R; Johns N; Engell RE; Flaxman A; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1564-74. PubMed ID: 23993281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
    Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Inflammatory Bowel Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Neurology Collaborators
    Lancet Neurol; 2019 May; 18(5):459-480. PubMed ID: 30879893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.